Angle PLC Announces Results of Eisai Phase 2 pilot study

UPDATE ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACTDevelopment of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZenecaResults of …
Jetzt den vollständigen Artikel lesen